What are the signs and symptoms of low estrogen levels in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs of Low Estrogen in Women

Low estrogen levels in women cause hot flashes, night sweats, vaginal dryness, painful intercourse, mood changes, sleep disturbances, and increased risk of osteoporosis and cardiovascular disease. 1, 2

Vasomotor Symptoms

  • Hot flashes and night sweats are the most common manifestations of low estrogen, affecting 50-80% of menopausal women 3, 4, 5
  • These vasomotor symptoms typically manifest as sudden feelings of warmth in the face, neck, and chest, or sudden strong feelings of heat and sweating 6, 7
  • Vasomotor symptoms typically last more than 7 years and can significantly interfere with quality of life in 15-20% of women 3, 8
  • Night sweats occur in approximately 44% of postmenopausal women with low estrogen 9

Genitourinary Symptoms (Genitourinary Syndrome of Menopause)

  • Vaginal dryness affects approximately 48-50% of postmenopausal women and is often chronic 2, 3, 9
  • Vaginal itching and burning sensation are common manifestations of estrogen deficiency 2
  • Painful intercourse (dyspareunia) occurs in approximately 26% of women with low estrogen levels 2, 9
  • Vaginal discharge, discomfort during urination, and urinary urgency are associated with hypoestrogenism 2
  • Unlike vasomotor symptoms which may resolve over time, genitourinary symptoms often persist indefinitely and typically worsen without treatment 2

Psychological and Sleep-Related Symptoms

  • Mood lability and feelings of depression affect approximately 44% of postmenopausal women with low estrogen 1, 9
  • Difficulty sleeping occurs in 44% of women and increases in frequency with increasing severity of vasomotor symptoms 9
  • The frequency of depression and sleep disturbance increases significantly with worsening vasomotor symptoms (P for trend ≤ 0.001) 9

Musculoskeletal and Systemic Effects

  • Pelvic soft tissue atrophy develops as a consequence of prolonged estrogen deficiency 1
  • Osteoporosis (thin, weak bones that are more prone to fracture) is a long-term consequence of hypoestrogenism 1, 6
  • Increased risk of cardiovascular disease is associated with low estrogen states 1

Athletic and Reproductive-Age Women

  • In exercising women with low energy availability, decreased estradiol levels occur alongside menstrual dysfunction (oligomenorrhea or amenorrhea) 1
  • Low estrogen in athletic women leads to decreased bone mineral density, decreased trabecular number, decreased cortical thickness, and increased risk of bone stress injuries 1
  • Hormonal alterations in low estrogen states include decreased progesterone, decreased leptin, increased ghrelin, and dysregulation of the growth hormone/IGF-1 axis 1

Clinical Context

  • The sudden drop in estrogen levels occurs naturally between ages 45-55 years during menopause, or can occur surgically when both ovaries are removed before natural menopause 6, 7
  • Approximately 50-75% of women experience vasomotor symptoms during the menopausal transition, and more than 50% experience genitourinary symptoms 3
  • Women using aromatase inhibitors (which inhibit peripheral conversion of androgens to estrogens by >95%) experience more severe symptoms of estrogen deficiency 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaginal Atrophy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Approach to the patient with menopausal symptoms.

The Journal of clinical endocrinology and metabolism, 2008

Research

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.